Status:
UNKNOWN
Comparison Study of Echocardiography and Cardiovascular Magnetic Resonance Imaging in the Assessment of Mitral and Aortic Regurgitation
Lead Sponsor:
Atlantic Health System
Conditions:
Mitral Regurgitation
Aortic Regurgitation
Eligibility:
All Genders
18+ years
Brief Summary
The primary treatment for patients determined to have severe aortic or mitral regurgitation is surgical repair or replacement their valves. The most commonly used tool to quantify the severity mitral ...
Detailed Description
The primary treatment for patients determined to have severe aortic or mitral regurgitation is surgical repair or replacement their valves. The most commonly used tool to quantify the severity mitral ...
Eligibility Criteria
Inclusion
- Age ≥18 years of age
- Able to give informed consent
- Referred for isolated aortic or mitral valve repair or replacement due to valve regurgitation
Exclusion
- Inability to provide consent.
- Pregnancy
- Claustrophobia
- Metallic contraindications to MRI (e.g. noncompatible aneurysm clip etc)
- Known intracardiac shunt
- Planned concomitant cardiac surgical procedure such as coronary artery bypass, septal myomectomy, or other valve procedure.
- More than mild mitral or aortic stenosis.
- For patients enrolled with mitral regurgitation: greater than mild aortic regurgitation.
- For patients enrolled with aortic regurgitation: greater than mild mitral regurgitation.
- Hypertrophic cardiomyopathy.
Key Trial Info
Start Date :
July 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04038879
Start Date
July 1 2010
End Date
July 1 2023
Last Update
August 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Morristown Medical Center
Morristown, New Jersey, United States, 07960